Literature DB >> 25149509

Combination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase.

Qing Jing1, Huiying Li2, Linda J Roman3, Pavel Martásek4, Thomas L Poulos5, Richard B Silverman6.   

Abstract

To develop potent and selective nNOS inhibitors, a new series of double-headed molecules with chiral linkers that derive from natural amino acid derivatives have been designed and synthesized. The new structures integrate a thiophenecarboximidamide head with two types of chiral linkers, presenting easy synthesis and good inhibitory properties. Inhibitor (S)-9b exhibits a potency of 14.7 nM against nNOS and is 1134 and 322-fold more selective for nNOS over eNOS and iNOS, respectively. Crystal structures show that the additional binding between the aminomethyl moiety of 9b and propionate A on the heme and tetrahydrobiopterin (H4B) in nNOS, but not eNOS, contributes to its high selectivity. This work demonstrates the advantage of integrating known structures into structure optimization, and it should be possible to more readily develop compounds that incorporate bioavailability with these advanced features. Moreover, this integrative strategy is a general approach in new drug discovery.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Heme; Nitric oxide synthase; Protein crystallography; Selective inhibition; Tetrahydrobiopterin; Thiophenecarboximidamide

Mesh:

Substances:

Year:  2014        PMID: 25149509      PMCID: PMC4204799          DOI: 10.1016/j.bmcl.2014.07.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Blocking NO synthesis: how, where and why?

Authors:  Patrick Vallance; James Leiper
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

Review 2.  Role of nitric oxide in Parkinson's disease.

Authors:  Li Zhang; Valina L Dawson; Ted M Dawson
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

Review 3.  Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

Authors:  L Salerno; V Sorrenti; C Di Giacomo; G Romeo; M A Siracusa
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

4.  Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.

Authors:  Jailall Ramnauth; Joanne Speed; Shawn P Maddaford; Peter Dove; Subhash C Annedi; Paul Renton; Suman Rakhit; John Andrews; Sarah Silverman; Gabriela Mladenova; Salvatore Zinghini; Sheela Nair; Concettina Catalano; David K H Lee; Milena De Felice; Frank Porreca
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

5.  Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.

Authors:  Subhash C Annedi; Jailall Ramnauth; Shawn P Maddaford; Paul Renton; Suman Rakhit; Gabriela Mladenova; Peter Dove; Sarah Silverman; John S Andrews; Milena D Felice; Frank Porreca
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

Review 6.  Nitric oxide and pain: 'Something old, something new'.

Authors:  A Miclescu; T Gordh
Journal:  Acta Anaesthesiol Scand       Date:  2009-08-21       Impact factor: 2.105

Review 7.  Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Authors:  Richard B Silverman
Journal:  Acc Chem Res       Date:  2009-03-17       Impact factor: 22.384

8.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

9.  N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.

Authors:  J L Collins; B G Shearer; J A Oplinger; S Lee; E P Garvey; M Salter; C Duffy; T C Burnette; E S Furfine
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

10.  Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.

Authors:  Soosung Kang; Wei Tang; Huiying Li; Georges Chreifi; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2014-05-07       Impact factor: 7.446

View more
  4 in total

1.  Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase.

Authors:  Jeffrey K Holden; Dillon Dejam; Matthew C Lewis; He Huang; Soosung Kang; Qing Jing; Fengtian Xue; Richard B Silverman; Thomas L Poulos
Journal:  Biochemistry       Date:  2015-06-23       Impact factor: 3.162

Review 2.  Nitric oxide synthase and structure-based inhibitor design.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Nitric Oxide       Date:  2016-11-23       Impact factor: 4.427

3.  2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.

Authors:  Soosung Kang; Huiying Li; Wei Tang; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

4.  Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus.

Authors:  Jeffrey K Holden; Soosung Kang; Federico C Beasley; Maris A Cinelli; Huiying Li; Saurabh G Roy; Dillon Dejam; Aimee L Edinger; Victor Nizet; Richard B Silverman; Thomas L Poulos
Journal:  Chem Biol       Date:  2015-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.